Summaries
-
NICE guidelineNICE type 1 diabetes guideline
This summary on type 1 diabetes in adults covers diagnosis, insulin therapy, and blood glucose management, and includes a useful algorithm
-
NICE guideline
NICE diabetes in pregnancy guideline
An up-to-date summary of NICE guidance on diabetes management in pregnancy. Includes gestational diabetes, preconception, antenatal, and postnatal care.
-
NICE guideline
NICE type 2 diabetes in children guideline
This succinct Guidelines summary advises on the appropriate diagnosis and management of type 2 diabetes mellitus in children and young people.
-
NICE guideline
NICE type 1 diabetes in children guideline
This summary includes recommendations on pharmacological therapy, and recognition and management of diabetic ketoacidosis.
-
NICE guideline
NICE type 2 diabetes guideline
This summary provides recommendations on blood glucose targets, patient education, and includes a useful algorithm on blood glucose management
-
Independent professional body guideline
KDIGO guideline on diabetes management in CKD
Recommendations on comprehensive care, glycaemic monitoring and targets, lifestyle and antihyperglycaemic interventions, and approaches to self-management and optimal models of care
-
Independent professional body guideline
PCDE pharmacological management of type 2 diabetes
This succinct summary highlights the treatment recommendations for type 2 diabetes by cardiovascular/renal disease or risk factor.
-
Independent professional body guideline
Type 2 diabetes pharmacological management pathway comparison
This comparison table summarises recommendations on the management of hyperglycaemia in adults with type 2 diabetes from ADA/EASD, NICE, and SIGN.
-
NICE guideline
Diabetic foot problems: prevention and management
This summary covers preventing and managing foot problems in children, young people and adults with diabetes. It aims to reduce variation in practice, including antibiotic prescribing for diabetic foot infections.
-
Working party guideline/algorithm
Guideline for the managed introduction of biosimilar basal insulin
This guideline was developed by a multidisciplinary expert panel: Down S et al with the support of an educational grant from Mylan.
-
Independent professional body guideline
Type 2 diabetes: frailty in older people
Summary covers glycaemic targets for older people, priorities for improving high-quality diabetes care, and a useful frailty assessment pathway.
-
Working party guideline/algorithm
Pancreatic exocrine insufficiency guideline
This management algorithm was developed by a multidisciplinary expert panel: Hambling C et al with the support of a grant from Mylan Ltd.
-
SIGN guideline
SIGN type 2 diabetes guideline
This summary provides key recommendations on lifestyle management, treatment options, diabetic CVD, and CKD. Includes a useful treatment algorithm
-
NICE guideline
NICE type 2 diabetes prevention guideline
This summarises NICE's guideline on the identification of people at high risk of type 2 diabetes and the provision of interventions for them.
-
Independent professional body guideline
JBDS hyperglycaemia and steroid therapy guideline
A concise summary of JBDSIP's guideline on the management of hyperglycaemia and steroid (glucocorticoid) therapy outlined in two useful algorithms
-
Independent professional body guideline
JBDS-IP undergoing surgery and elective procedures guideline
This useful summary provides recommendations for primary care, and includes a GP letter with recommendations for referral of patients for surgery.
-
NICE guideline
NICE type 2 diabetes: population and community-level interventions
This summarises NICE's guideline on population and community-level interventions to prevent type 2 diabetes.
![20200212 Guidelines comparison tablev10 [online] UPDATED 2020 v4](https://d3j7puhwqgd8ts.cloudfront.net/Pictures/100x67//9/3/4/6934_20200212guidelinescomparisontablev10onlineupdated2020v4_419801.png)
